Human IKK gamma/NEMO enzyme-linked immunoassay kit

CAT: EH0324 Datasheet
Specification 96 Test
Sensitivity 2.0 pg/ml (50 μl)
Standard Curve Range 31.25~2000 pg/ml
Standard Curve Gradient 7 Points
Number of Incubations 2
Detectable sample Liquid phase sample of soluble substances. For example: serum, plasma, cell culture supernatant, tissue grinding liquid, etc.
Sample Volume 50 μl/10 μl
Type Fully Ready-to-Use
Operation Duration 120min
pg/ml O.D. Average Corrected
0.00 0.0357 0.0330 0.0344
31.25 0.0975 0.0863 0.0919 0.0576
62.50 0.1553 0.1381 0.1467 0.1124
125.00 0.2683 0.2467 0.2575 0.2232
250.00 0.5123 0.4686 0.4905 0.4561
500.00 0.9761 0.9020 0.9391 0.9047
1000.00 1.8510 1.6800 1.7655 1.7312
2000.00 3.3560 3.1000 3.2280 3.1937

Precision

Intra-assay Precision Inter-assay Precision
Sample Number S1 S2 S3 S1 S2 S3
22 22 22 6 6 6
Average(pg/ml) 25.5 161.0 521.3 25.4 164.0 528.7
Standard Deviation 1.1 4.6 11.1 2.0 6.7 17.6
Coefficient of Variation(%) 4.3 2.8 2.1 7.9 4.1 3.3

Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty-two times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.

Spike Recovery

The spike recovery was evaluated by spiking 3 levels of human IKK gamma/NEMO into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 75% to 95% with an overall mean recovery of 82%.

Sample Values

Sample Matrix Sample Evaluated Range (pg/ml) Detectable (%) Mean of Detectable (pg/ml)
Serum3015.39-70.9810037.33

Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of human IKK gamma/NEMO in this assay. No medical histories were available for the donors. n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.

Background: IKK gamma/NEMO

NF-kB (nuclear factor kB) is sequestered in the cytoplasm by IkB family of inhibitory proteins that mask the nuclear localization signal of NF-kB thereby preventing translocation of NF-kB to the nucleus. External stimuli such as tumor necrosis factor or other cytokines results in phosphorylation and degradation of IkB releasing NF-kB dimers. NF-kB dimer subsequently translocates to the nucleus and activates target genes. Synthesis of IkBa is autoregulated. IkB proteins are phosphorylated by IkB kinase complex consisting of at least three proteins, IKK1/a, IKK2/b, and IKK3/g. IKK3/g preferentially interacts with IKK2/b and is required for activation of IKK complex. IKK3/g is also known as NEMO (NF-kB Essential MOdulator). Recent data suggest that the human T-cell leukemia virus type I Tax oncoprotein that activates NF-kB binds neither to IKKa nor IKKb, but complexes directly with IKKg. This suggests that IKKg may be a key molecule acting as an adapter for onco-protein specific signaling to IKKa and IKKb.

Under construction!

Under construction!

Under construction!

Contact Information
Related Products
相关途径
Guarantee